Showing results (181-190 of 916) with videos related to
Sort By:
Pageof 92
Current Hematologic Malignancy Reports|February 10, 2018
Novel Therapies for Older Adults With Acute Lymphoblastic LeukemiaNicholas J Short, Hagop Kantarjian, Elias Jabbour, et al.Clinical Lymphoma, Myeloma & Leukemia|May 22, 2026
SOHO State of the Art Updates and Next Questions | Management of High-Risk Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWalid Macaron, Hagop Kantarjian, Elias Jabbour, et al.Nature Communications|March 7, 2023
Variability conceals emerging trend in 100yr projections of UK local hourly rainfall extremesElizabeth J Kendon, Erich M Fischer, Chris J ShortJournal of the American Academy of Child and Adolescent Psychiatry|January 5, 2002
Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorderR L Findling, E J Short, M J ManosCell Biology International|August 30, 2008
Characterization of water of hydration fractions in rabbit skeletal muscle with age and time of post-mortem by centrifugal dehydration force and rehydration methodsIvan L Cameron, Nicholas J Short, Gary D FullertonCancer Journal (Sudbury, Mass.)|January 24, 2022
The Evolution of Research and Therapy With Hypomethylating Agents in Acute Myeloid Leukemia and Myelodysplastic Syndrome: New Directions for Old DrugsNicholas J Short, Hervé Dombret, Lionel Adès, et al.Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 8, 2009
Quantum mechanical evolution towards thermal equilibriumNoah Linden, Sandu Popescu, Anthony J Short, et al.Cell Biology International|February 3, 2007
A simple centrifugal dehydration force method to characterize water compartments in fresh and post-mortem fish muscleIvan L Cameron, Nicholas J Short, Gary D FullertonBest Practice & Research. Clinical Haematology|October 21, 2017
Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?Nicholas J Short, Hagop Kantarjian, Elias Jabbour, et al.Journal of Hematology & Oncology|May 11, 2024
Inotuzumab ozogamicin for the treatment of adult acute lymphoblastic leukemia: past progress, current research and future directionsNicholas J Short, Elias Jabbour, Nitin Jain, et al.Pageof 92